The results of the study showed that SGLT2 inhibitor dapagliflozyn modified the levels of apelin depending on the phenotype of HF, exerting most meaningful effect in patients with HFpEF rather than HFmrEF or HFrEF. Here, APLN is linked to hydrops fetalis.